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Tissue  invasion  during  metastasis  re-
quires cancer cells to negotiate a stromal 
environment dominated by cross-linked 
networks  of  type  I  collagen.  Although 
cancer cells are known to use proteinases 
to sever collagen networks and thus ease 
their passage through these barriers, mi-
gration across extracellular matrices has 
also been reported to occur by protease-
independent mechanisms, whereby cells 
squeeze through collagen-lined pores by 
adopting  an  ameboid  phenotype.  We 
investigate these alternate models of mo-
tility here and demonstrate that cancer 
cells  have  an  absolute  requirement  for 
the membrane-anchored metalloprotein-
ase  MT1-MMP  for  invasion,  and  that 
protease-independent  mechanisms  of 
cell  migration  are  only  plausible  when 
the collagen network is devoid of the   
covalent cross-links that characterize nor-
mal tissues.
Barriers to cell migration: 
prevailing theories
After  neoplastic  transformation,  can-
cer cells infiltrate local tissues and ini-
tiate metastatic programs by trafficking 
through a stromal extracellular matrix 
(ECM) dominated by cross-linked net-
works of type I collagen, the major ex-
tracellular  protein  found  in  mammals 
(Brown et al., 2003; Sabeh et al., 2004; 
Demou et al., 2005; Oldberg et al., 2007; 
Magzoub et al., 2008). To negotiate this 
structural barrier, cancer cells have been 
proposed to use either protease-dependent 
or protease-independent invasion schemes 
(Wolf  et  al.,  2003a,b,  2007;  Sabeh   
et  al.,  2004;  Wilkinson  et  al.,  2005;   
Carragher et al., 2006; Wyckoff et al., 
2006; Gaggioli et al., 2007; Croft and 
Olson,  2008;  Gadea  et  al.,  2008;  Li   
et  al.,  2008;  Pinner  and  Sahai,  2008; 
Sanz-Moreno et al., 2008; Packard et al.,   
2009). Protease-dependent invasion pro-
grams rely on matrix metalloproteinase 
(MMP) family members to cleave im-
peding  collagen  fibrils  (Sabeh  et  al., 
2004; Fisher et al., 2006; Hotary et al., 
2006; Itoh and Seiki, 2006; Li et al., 2008; 
Packard et al., 2009). Alternatively, ne-
gotiation  of  collagenous  barriers  has 
been reported to proceed in a protease-
independent  fashion,  whereby  cancer 
cells use actomyosin-based mechanical 
forces  to  physically  displace  matrix   
fibrils  while  coordinately  adopting  an 
amoeboid-like cell shape similar to that 
observed  in  myeloid  cell  populations 
(Friedl  and  Wolf,  2003;  Wolf  et  al., 
2003a,b, 2007; Wilkinson et al., 2005; 
Carragher et al., 2006; Wyckoff et al., 
2006;  Gadea  et  al.,  2008;  Pinner  and 
Sahai, 2008; Sanz-Moreno et al., 2008). 
Indeed, in recent clinical trials, the fail-
ure of MMP inhibitors to prevent cancer 
Protease-dependent versus -independent cancer cell 
invasion programs: three-dimensional amoeboid 
movement revisited
Farideh Sabeh, Ryoko Shimizu-Hirota, and Stephen J. Weiss
Division of Molecular Medicine and Genetics, Department of Internal Medicine, Life Sciences Institute, University of Michigan, Ann Arbor, MI 48109
Correspondence  to  Stephen  J.  Weiss:  sjweiss@
umich.edu
© 2009 Sabeh et al.  This article is distributed under the 
terms  of  an  Attribution–Noncommercial–Share  Alike–No 
Mirror Sites license for the first six months after the pub-
lication  date  (see  http://www.jcb.org/misc/terms.shtml). 
After six months it is available under a Creative Commons 
License  (Attribution–Noncommercial–Share  Alike  3.0  Un-
ported  license,  as  described  at  http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
3D cancer cell invasion. Multicellular spheroids of HT-1080 fibrosarcoma cells were embedded within 
3D gels of native type I collagen for 3 d. Gels were fixed in 2% glutaraldehyde/1.5% paraformalde-
hyde in 0.1 M sodium cacodylate buffer, freeze-fractured, and processed for SEM. Images of infiltrat-
ing cells and the surrounding ECM were digitally imaged using XStream imaging software.
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progression  suggests  that  protease-
  independent  mechanisms  of  invasion 
may be physiologically relevant in vivo 
(Friedl and Wolf, 2003; Wilkinson et al., 
2005; Sahai et al., 2007; Wolf et al., 2007). 
However,  descriptions  of  proteinase-
  independent, amoeboid-like cancer cell 
behavior are largely drawn from in vitro 
assays using model, three-dimensional 
(3D) ECM constructs that may not re-
capitulate the key structural characteris-
tics displayed by native type I collagen 
networks in vitro or in vivo (Sabeh et al., 
2004; Demou et al., 2005; Hotary et al., 
2006; Packard et al., 2009). As such, the 
relative importance of protease-dependent 
and  -independent  invasion  modalities 
mobilized during cancer cell trafficking 
through  interstitial  barriers  remains  a 
subject of considerable debate.
MT1-MMP, synthetic 
MMP inhibitors, and the 
3D cancer cell invasion 
program
To recreate an in vivo–like environment 
for migrating cancer cells, multicellular 
spheroids of HT-1080 fibrosarcoma cells 
were embedded within 3D gels of native 
type  I  collagen  (Hotary  et  al.,  2003; 
Sabeh et al., 2004; Li et al., 2008). HT-1080 
cells subsequently activate a tissue-invasive 
program and infiltrate the surrounding 
ECM in a “starburst” pattern (Fig. 1 A). 
Migrating  HT-1080  cells  express  at 
least three distinct type I collagenolytic 
systems  under  these  conditions:  the   
secreted  metalloenzymes,  MMP-1  and 
MMP-2,  as  well  as  the  membrane- 
anchored proteinase, MT1-MMP (Fig. 1 B) 
(Sabeh et al., 2004; Li et al., 2008). After 
siRNA-dependent  silencing  of  both 
MMP-1  and  MMP-2  in  combination, 
HT-1080  spheroids  retain  full  invasive 
activity (Fig. 1, A–C). In contrast, MT1-
MMP silencing blocks virtually all inva-
sive  activity  over  a  3-d  culture  period 
(Fig. 1 A). Invasive activity is, however, 
rescued when MT1-MMP–silenced cells 
are  electroporated  with  an  expression 
vector for mouse MT1-MMP, an ortho-
logue that escapes targeting by the human-
specific  MT1-MMP  siRNA  (Fig.  1, A 
and  C).  Similar  results  are  obtained 
Figure  1.  Regulation  of  cancer  cell–invasive 
phenotype in 3D type I collagen by MT1-MMP. 
(A)  Di-I–labeled  multicellular  spheroids  (150–
200 µm in diameter) of HT-1080 cells or MDA-
MB-231 cells were prepared in hanging droplets 
(Kelm et al., 2003) after electroporation with a 
control siRNA, MMP-1 and MMP-2 siRNAs, MT1 
siRNA (50–100 nM; siRNA sequences can be 
found  in  Li  et  al.  [2008]  and  Sabeh  et  al. 
[2004]), or cotransfected with MT1 siRNA and 
either mouse (m)MT1-MMP or a control expres-
sion vector (0.5 µg each in PCR3.1 Uni; gift of 
M.  Seiki,  University  of  Tokyo,  Tokyo,  Japan;   
Sabeh et al., 2004; Li et al., 2008), and embed-
ded in 3D type I collagen gels (prepared from 
acid extracts of rat tail tendon as described pre-
viously [Sabeh et al., 2004] and visualized by 
SEM  in  the  left-hand  panel,  top  corner  inset;   
bar = 5 µm) at a final concentration of 2.2 mg/ml   
in the absence or presence of 10 µM GM6001. 
Invasion was monitored by fluorescence micros-
copy at 0 d (top row of panels) and by confocal 
microscopy at 3 d after staining with Alexa-488 
phalloidin and DAPI (bottom row of panels; Di-I, 
red; Alexa-488 phalloidin, green; DAPI, blue). 
For MDA-MB-231 cells (bottom row of panels), 
spheroid at 0 d are shown in the insets. Bar = 
100 µm. (B) MT1-MMP, MMP-1, and MMP-2 siR-
NAs inhibited expression of the targeted MMPs 
in HT-1080 cells, but had no effect on the expres-
sion of nontargeted MMPs as shown by RT-PCR. 
(C)  Invasion  distance  (quantified  as  described 
previously; [Hotary et al., 2000; Sabeh et al., 
2004])  from  the  inoculation  site  into  the  sur-
rounding matrix was monitored at 1 d and 3 d 
for HT-1080, MDA-MB-231, or SUM-159 cells. 
In the presence of a protease inhibitor cocktail 
directed against serine, aspartyl, cysteinyl, and 
matrix metallo-proteinases (Wolf et al., 2003a), 
HT-1080 invasion was inhibited by 99 ± 0%.   
Results are expressed as mean ± SEM (n = 4).   
(D) HT-1080 cell spheroids were embedded in 
type I collagen gels in the absence or presence of 
the indicated doses of BB-2516 for 3 d. Insets 
show the spheroid at 0 d after Di-I labeling and 
the migration of the cells after 3 d is shown in the 
bottom row of companion panels. Bar = 100 µm. 
The percentage of inhibition of invasion at 40, 
100, and 500 ng/ml (1.5 µM) BB-2516 was   
59 ± 4%, 86 ± 2%, and 99 ± 0%, respectively.JCB: FEATURE
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with  MT1-MMP–silenced  MDA-MB-
231 breast cancer cells or the breast can-
cer  stem  cell–enriched  SUM-159  line 
(Fig. 1, A and C) (Korkaya et al., 2008).
The impact of silencing MT1-MMP 
alone  on  cancer  cell–invasive  activity 
stands in contrast with the failure of pep-
tidomimetic MMP inhibitors (e.g., BB-
2516/marimastat)  to  exert  beneficial 
effects  in  previously  reported  clinical 
cancer trails (Overall and Kleifeld, 2006). 
Importantly,  however,  the  peak  plasma 
concentrations recorded in most patients 
(i.e.,  10–40  ng/ml)  (Sparano  et  al., 
2004)  falls  below  the  concentration   
required to completely block MT1-MMP–
dependent invasive activity in 3D assays 
(i.e., 500 ng/ml; Fig. 1 D). Thus, the in-
effectiveness of MMP inhibitors to exert 
palliative effects in cancer patients may 
reflect a requirement for drug concentra-
tions in excess of those achievable in the 
clinical setting, and does not necessar-
ily support the existence of protease-
independent invasive activity in vivo.
Type I collagen cross-links 
dictate the rules of invasion
The  inability  of  MT1-MMP–silenced 
HT-1080 or MDA-MB-231 cells to adopt 
an  invasive,  amoeboid  phenotype-type 
when embedded in 3D type I collagen 
gels  contradicts  recent  reports  using 
identical cell lines (Wolf et al., 2003a,b, 
2007;  Demou  et  al.,  2005;  Carragher   
et al., 2006). However, matrices used in 
these  studies  were  reconstituted  from 
pepsin-extracted  type  I  collagen  (e.g., 
Vitrogen), a proteolytic process that re-
moves the nonhelical telopeptides situ-
ated at the N- and C-terminal ends of 
native  collagen  molecules  (Fig.  2  A) 
(Wolf  et  al.,  2003a,b,  2007;  Demou   
et al., 2005; Carragher et al., 2006; Gadea 
et al., 2008; Sanz-Moreno et al., 2008). 
Figure  2.  MT1-MMP–independent  tumor  cell 
invasion through telopeptide-excised or cross-
link–deficient type I collagen gels. (A) Schematic 
of type I collagen intermolecular cross-links. In 
vivo, lysyl oxidase generates aldehyde moieties 
within  the  N-  and  C-terminal  telopeptide  do-
mains  of  type  I  collagen,  which  are  arrayed 
across from -amino groups (boxed region) that 
spontaneously condense to conform Schiff base, 
aldimine cross-links in vivo. N- and C-terminal 
telopeptides are removed during pepsin extrac-
tion  (arrows).  Under  acidic  extraction  condi-
tions,  Schiff  base  formation  is  reversed  to 
generate  the  starting  aldehyde  and  amine 
groups.  After  treatment  with  sodium  boro-
hydride, aldehydes are converted to alcohols that 
no longer support cross-linked formation. (B) Di-
I-labeled  multicellular  spheroids  of  HT-1080 
cells, electroporated with control or MT1 siRNA, 
were  embedded  in  3D  gels  prepared  from   
either pepsin-extracted bovine dermis (Vitrogen; 
2.2 mg/ml) or pepsin-extracted rat tail tendon 
and monitored by fluorescence microscopy at   
0 d (top row of panels) and after 1 d (second row 
of  panels;  Di-I,  red;  Alexa-488  phalloidin, 
green; DAPI, blue). SEM of pepsin-extracted col-
lagen gels is shown in the inset of a 0-d spher-
oid electroporated with control siRNA (left-hand 
panel in the first row; bar = 5 µm). GM6001 
(10 µM) was added to the cultures at 0 d in the 
right-hand column of panels. Bar, 100 µm. In 
the bottom row of panels, Di-I-labeled HT-1080 
spheroids  were  embedded  in  borohydride- 
reduced, rat tail type I collagen gels (2.2 mg/ml) 
at 0 d (insets) and invasion monitored 1 d later 
after electroporation with a control siRNA, MT1-
MMP siRNA or after culture in the presence of 
GM6001.  Collagen  aldehyde  content  before 
and  after  borohydride  reduction  was  deter-
mined spectrophotometrically (Williams et al., 
1978; Gelman et al., 1979). After the 1-d cul-
ture period, cells were stained with Alexa-488 
phalloidin  and  DAPI  as  described  above.   
Bar,  100  μm.  (C)  HT-1080  or  MDA-MB-231 
spheroids were cultured for 1 d in 3D pepsinized 
or reduced type I collagen and invasion distance 
into the surrounding matrix quantified. HT-1080 
invasion in the presence of a protease inhibitor 
cocktail (Wolf et al., 2003a) in pepsinized or 
reduced collagen gels was inhibited by 0 ± 0% 
and 8 ± 1%, respectively. Results are expressed 
as mean ± SEM (n = 4). Acid-extracted, pepsin- 
extracted, and reduced collagen fibrils are equally 
trypsin resistant (not depicted).JCB • VOLUME 185 • NUMBER 1 • 2009   14
These collagen telopeptides play impor-
tant roles in fibrillogenesis and contain 
critical lysine residues which, after lysyl 
oxidase-dependent  oxidation  in  vivo, 
support  the  intermolecular  covalent 
cross-links necessary for stabilizing gel 
architecture (Gelman et al., 1979; Brennan 
and Davison, 1980; Eyre et al., 1984; 
Woodley et al., 1991; Christiansen et al., 
2000; Sato et al., 2000). It is therefore 
possible that the ability of cancer cells to 
display  proteinase-independent,  amoe-
boid  activity  may  be  affected  by  the 
structural  integrity  of  the  reconstituted 
collagen gel used for in vitro assay.
Following  gel  formation  under 
conditions  identical  to  those  used  for 
full-length, native type I collagen, pepsin-
extracted collagen form fibrillar networks 
indistinguishable from those obtained 
with telopeptide-intact collagen as as-
sessed  by  SEM  (Fig.  2  B).  However, 
whereas  control  collagen  gels  are  in-
soluble  in  high  salt  buffers,  collagen 
matrices prepared from pepsin-extracted 
material rapidly solubilize, a physico-
chemical behavior characteristic of cross-
linked versus noncross-linked collagen 
gels, respectively (Gelman et al., 1979). 
HT-1080 spheroids embedded in pepsin-
extracted  collagen  gels  infiltrate  the 
matrix in a single-cell fashion with the 
invasive front displaying a mix of both 
spheroid-  and  elongated-shaped  cells 
(Fig.  2  B).  Within  24  h,  migrating   
HT-1080  cells  invade  the  pepsin-
  extracted gels to distances that require a 
72-h  incubation  period  in  full-length 
type I collagen matrices (Fig. 2 B vs. 
Fig.  1  C).  Neither  MT1-MMP  silenc-
ing,  the  addition  of  the  pan-specific 
MMP inhibitor GM6001, nor the inclu-
sion  of  a  broad-spectrum  cocktail  of 
proteinase inhibitors (Wolf et al., 2003a) 
exert inhibitory effects on either HT-1080 
or MDA-MB-231 cell invasion (Fig. 2, 
B and C).
Type  I  collagen  telopeptides  po-
tentially regulate invasion by either af-
fecting the linear or lateral stages of the 
fibrillogenic process, or by supporting col-
lagen cross-link formation (Gelman et al., 
1979; Woodley et al., 1991; Christiansen 
et al., 2000; Sato et al., 2000). Intact 
collagen  can  be  acid-extracted  in  al-
most pure form from tissues of young 
animals because a subset of the lysyl 
oxidase-catalyzed, collagen cross-links 
formed  in  vivo  are  acid-labile,  Schiff 
base  adducts  (Fig.  2 A)  (Eyre  et  al., 
1984). At low pH these cross-links are 
reversibly broken, resulting in the for-
mation  of  aldehyde-bearing  collagen 
molecules that are fully soluble in low 
ionic strength, acidic buffers (Fig. 2 A) 
(Eyre et al., 1984). The Schiff base ad-
ducts that interconnect collagen bundles 
are reformed spontaneously when col-
lagen gels are reconstituted at neutral 
pH, but this cross-linking process can 
be  prevented  by  chemically  reducing 
the aldehyde moieties before gel forma-
tion (Fig. 2 A) (Gelman et al., 1979). 
When HT-1080 cells are embedded in 
3D gels of aldehyde-reduced type I col-
lagen, the cells exhibit the more rapid 
speed of infiltration observed in pepsin-
extracted  collagen  gels  and  neither 
MT1-MMP  silencing  nor  the  addition 
of  GM6001  significantly  inhibits  HT-
1080 or MDA-MB-231 invasion (Fig. 2, 
B and C). As the pore size of collagen 
gels prepared from intact and pepsin-
extracted collagen are similar (Demou 
et  al.,  2005),  we  conclude  that  MT1-
MMP–independent  invasion  only  pro-
ceeds when the structural pores formed 
in collagen gel networks are no longer 
stabilized  by  the  covalent  cross-links 
that define fibril architecture and struc-
tural rigidity (Zaman et al., 2006).
Crossing an authentic 
stromal barrier: the human 
mammary gland interstitium
Reconstituted gels of native type I col-
lagen  provide  important  insights  into 
the structural and mechanical proper-
ties that regulate cancer cell behavior, 
but the precise architecture of the fi-
brillar  networks  assembled  in  vivo 
cannot  be  duplicated  fully  in  vitro 
(Christiansen et al., 2000; Raub et al., 
2007,  2008).  To  define  the  relative 
roles of protease-dependent and -inde-
pendent  invasion  programs  in  live   
tissue,  we  implanted  MDA-MB-231 
breast  cancer  cell  spheroids  into  ex-
plants of the normal human mammary 
gland, and transplanted the composites 
atop  the  live  chick  chorioallantoic 
membrane (Sabeh et al., 2004). In this 
xenograft model, cancer cell spheroids 
embedded within the mammary gland 
rapidly  infiltrate  the  surrounding  tis-
sues during a 72-h culture period (Fig. 
3 A). Although both MMP-1 and MMP-2 
can modulate breast cancer behavior in 
vivo (Tester et al., 2004; Wyatt et al., 
2005;  Gupta  et  al.,  2007),  silencing 
both proteases in tandem does not af-
fect MDA-MB-231 or SUM-159 inva-
sion (Fig. 3 B). MT1-MMP knockdown, 
in contrast, potently inhibits the ability 
of the breast cancer cells to infiltrate   
or  degrade  surrounding  breast  tissue 
(Fig. 3, A and B). The inhibitory effects   
exerted  by  the  human-specific  MT1-
MMP siRNA are reversed by expressing 
mouse  MT1-MMP  in  the  siRNA-
treated  MDA-MB-231  or  SUM-159 
cells (Fig. 3, A and B). Hence, MT1-
MMP not only supports 3D cancer cell 
invasion through reconstituted gels of 
cross-linked collagen, but also within 
the stromal environment of the mam-
mary gland.
3D matrix architecture 
defines the mode of cancer 
cell invasion
In reconstituted gels of native type I col-
lagen, pore size is limited to 1 µm in di-
ameter (Demou et al., 2005). The motile 
activity  of  MT1-MMP–inhibited  spher-
oids  into  collagen  pores  was  restricted 
under our experimental conditions to ex-
tensions  of  filopodia-like  structures  or 
motile cell fragments (Mayer et al., 2004). 
Thus, the network of rigid pores stabi-
lized by covalent cross-links between col-
lagen fibrils pose a significant structural 
constraint to the mobility of cancer cells. 
Current evidence suggests that a migrat-
ing cancer cell has limited ability to me-
chanically negotiate a rigid pore whose 
diameter is significantly smaller than that 
of the cell’s nucleus, the largest and most 
rigid of its intracellular organelles (Lutolf 
et al., 2003; Demou et al., 2005; Lutolf 
and  Hubbell,  2005;  Nakayama  et  al., 
The precise architecture 
of fibrillar networks 
assembled in vivo 
cannot be duplicated 
fully in vitro.JCB: FEATURE
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2005; Raeber et al., 2005, 2007; Ehrbar   
et al., 2007; Wolf and Friedl, 2008). As 
collagen  gel  microstructure  can  be  af-
fected by temperature, pH, ionic strength, 
ion  stoichiometry,  and  monomer  con-
centration  (Roeder  et  al.,  2002;  Raub   
et al., 2007, 2008), minor but significant 
changes in experimental conditions could 
affect results obtained by different labo-
ratories. However, fiber diameters gener-
ated under our standard in vitro conditions 
(60 nm as assessed by SEM) are similar 
to those deposited at tumor sites in vivo 
(Oldberg et al., 2007). Further, the pore 
sizes generated under our in vitro condi-
tions are consistent with the recent dem-
onstration  that  100-nm  beads  injected 
into type I collagen-rich tissues in vivo 
fail to diffuse significant distances from 
the injection site (McKee et al., 2006; 
Nagano et al., 2008). Though a subset of 
studies describing cancer cell amoeboid 
activity  have  used  acid-extracted  colla-
gen,  the  degree  of 
collagen  cross-link-
ing or pore size was 
not assessed (Wyck-
off  et  al.,  2006). 
These caveats aside, 
type I collagen auto-
assembly in vitro and 
cell-mediated assem-
bly in vivo are mech-
anistically  distinct 
processes (Raub et al., 2007, 2008). In 
vivo, collagen fibrils can be larger in size, 
incorporate a variety of other ECM com-
ponents, and display distinct mechanical 
properties  (Raub  et  al.,  2007,  2008). 
Therefore,  due  caution  should  be  exer-
cised when interpreting data from in vi-
tro  assays  using  reconstructed  collagen   
matrices.  Neverthe-
less,  breast  cancer 
cells embedded in hu-
man mammary gland 
explants  remain  reli-
ant  on  MT1-MMP–
  dependent proteolysis, 
leading  us  to  con-
clude that carcinoma 
cells migrating into 
physiologically  rele-
vant  tissues  are  confronted  with  matrix 
barriers similar to those generated in vitro 
from  full-length,  covalently  cross-linked 
fibrils of type I collagen.
Figure  3.  MT1-MMP drives cancer cell inva-
sion  in  human  mammary  gland  explants.  
(A) MDA-MB-231 Di-I–labeled spheroids (com-
prised  of  cells  electroporated  with  a  control 
siRNA, MT1-MMP siRNA or MT1-MMP siRNA 
together  and  a  mouse  MT1-MMP  expression 
vector) were injected (30-gauge needle) into hu-
man mammary gland explants (6 × 8 x 6 mm) 
and the position of the cancer cell aggregates 
recorded by fluorescence microscopy at 0 d. 
Bar = 20 µm. Inset shows SEM of type I collagen 
fibrils in mammary gland explant. Bar = 5 µm. 
The  inoculated  explants  were  then  cultured 
atop the live chick CAM for 3 d. Invasive be-
havior of MDA-MB-231 cells was monitored by 
fluorescence microscopy after labeling of mam-
mary gland tissues with Alexa-488 phalloidin 
and DAPI. Bar = 200 µm. Immunofluorescent 
staining of mammary tissue cross sections at 
d 3 (inserts) reveal tracts of denatured collagen 
detected  with  monoclonal  antibody  HU177 
(Hotary  et  al.,  2003;  Sabeh  et  al.,  2004) 
(green; arrows) surrounding invasive tumor cells 
(red), but not MT1-MMP–silenced cancer cells 
(bottom panels; bar = 10 µm). (B) Invasion dis-
tance for MDA-MB-231 or SUM-159 spheroids 
(electroporated with control siRNA, MMP-1 and 
MMP-2 siRNAs, MT1-MMP siRNA or MT1-MMP 
siRNA in combination with a mouse MT1-MMP 
expression vector) was quantified after a 3-d 
culture period in human mammary gland ex-
plants as described. Results are expressed as 
mean ± SEM (n = 3). (C) Invasion distance for 
MDA-MB-231 or SUM-159 spheroids (electro-
porated with control siRNA, MMP-1 and MMP-2 
siRNAs, MT1-MMP siRNA or MT1-MMP siRNA 
in combination with a mouse MT1-MMP expres-
sion vector) was quantified after a 3-d culture 
period in mouse mammary gland explants as 
described.  Results  are  expressed  as  mean  ± 
SEM (n = 3).
Caution should be 
exercised when 
interpreting data 
from in vitro assays 
using reconstructed 
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Extending the caveat 
emptor of using cross-link–
free matrix barriers
Independent of the mechanisms used by 
cancer cells to traverse stromal barriers, 
increasing attention has also focused on 
the  reported  ability  of  cancer  cells  to   
undergo a mesenchymal-amoeboid tran-
sition as they cross the basement mem-
brane,  a  specialized  ECM  barrier  that 
surrounds or underlies epithelial cells, 
muscle,  nerves,  and  the  endothelium 
(Wang et al., 2003; Zaman et al., 2006; 
Gadea et al., 2007; Kitzing et al., 2007; 
Sahai, 2007; Wolf et al., 2007; Fackler and 
Grosse, 2008; Rowe and Weiss, 2008). 
However, conclusions regarding proteinase- 
independent,  amoeboid-type  trafficking 
across basement membranes have been 
similarly based on artificial ECM com-
posites such as Matrigel, a noncovalently 
cross-linked  extract  of  basement  mem-
brane macromolecules whose structural 
organization fails to recapitulate that ob-
served in vivo (Even-Ram and Yamada, 
2005;  Hotary  et  al.,  2006;  Rowe  and 
Weiss, 2008; Sodek et al., 2008). Using 
authentic  basement  membranes  recov-
ered from mouse or human tissues, can-
cer cells likewise use MT1-MMP activity 
to  traverse  these  cross-linked  barriers 
(Hotary et al., 2006).
What’s more to be done?
At the end of the day, it is unlikely that 
the complex milieu of the in vivo envi-
ronment can be duplicated fully in vitro. 
Changes in oxygen tension, pH, contact 
guidance,  and  cancer  cell–stromal  cell 
crosstalk, as well as the growth factor/
cytokine  milieu  within  this  microenvi-
ronment could induce changes in cancer 
cell behavior that are unique to the neo-
plastic  site  (Anderson  et  al.,  2006; 
Provenzano et al., 2008b; Doyle et al., 
2009). Dissecting the relative role of 
protease-dependent and -independent traf-
ficking mechanisms in vivo will require 
the marriage of sophisticated 4D intravital 
A requirement for MT1-MMP activity during stromal invasion in vitro or ex vivo contrasts with recent reports documenting amoeboid movement of 
breast cancer cells in the in vivo setting, particularly within the mouse mammary gland (Wyckoff et al., 2006, 2007; Xue et al., 2006; Sahai, 2007; 
Sahai et al., 2007). The density of collagen fibrils in the mouse mammary gland is lower than that displayed in humans (Parmar and Cunha, 2004), 
but we can likewise document a requirement for MT1-MMP in mouse explants (Fig. 3 C). In vivo models of real-time movement, however, monitor 
the short-term trafficking of cancer cells (i.e., observation periods ranging from 20 min to 4 h) from primary sites established 1–3 months in advance 
of microscopic analyses (Sahai, 2007; Sanz-Moreno et al., 2008). Under these conditions, rapid motility and protease-independent, amoeboid-like 
activity might be accommodated under specific circumstances.
Cancer cells could display rapid, protease-independent cell movement in vivo by co-opting preexisting matrix tunnels gener-
ated by tumor-infiltrating fibroblasts, smooth muscle cells, or endothelial cells that bore through tissues in an MT1-MMP–de-
pendent process (Hiraoka et al., 1998; Chun et al., 2004; Sabeh et al., 2004; Filippov et al., 2005; Gaggioli et al., 2007). 
Likewise, damaged blood vessels or lymphatics as well as zones of necrosis could also present migrating cancer cells with 
“pre-cleared” passageways (Nagano et al., 2008). Indeed, rapid rates of cancer cell migration noted in several studies seem 
to occur within sites wherein the extensive loss of ECM networks has already occurred (Condeelis and Segall, 2003). In con-
trast, early phases of the tumor cell invasion program proceed through collagen-rich areas whose penetration would appear 
to be more consistent with the slower advance of proteolytically active neoplastic cell populations (Li et al., 2000; Curino   
et al., 2005; Provenzano et al., 2006, 2008a; Kedrin et al., 2008).
In vivo, cancer cells migrating away from the primary inoculation site potentially move into a na-
scent matrix deposited by infiltrating stromal cells which could contain defects in collagen cross-linking 
(Kauppila et al., 1998, 1999; Demou et al., 2005). Protease-independent invasion programs may, 
therefore, be accommodated by an immature, wound-like environment at sites distant from the neo-
plastic point-of-origin.
Given that only small numbers of carcinoma cells display rapid movement in vivo (Wyckoff et al., 2006, 2007; Xue et al., 
2006; Sahai, 2007; Sahai et al., 2007), the issue arises as to the precise origin of this cell type. Cancer cell–macrophage 
hybrids have been characterized that may acquire the potential to access the myeloid-specific amoeboid phenotype (Vignery, 
2005; Pawelek and Chakraborty, 2008). Indeed, cancer cell populations used in our studies are only able to traverse cross-
linked type I collagen barriers by mobilizing MT1-MMP, even when collagen fiber pore size is increased from 8 µm
2 to 80 
µm
2 by decreasing the polymerization pH of the collagen gels from pH 8.5 to pH 5.5 (Raub et al., 2008) (Fig. 4, A and B). 
In contrast, myeloid cells such as polymorphonuclear leukocytes, T cells, and monocytes, can rapidly infiltrate identical matri-
ces without altering collagen architecture or structure via a process resistant to MMP-specific or broad-spectrum protease in-
hibitors (Fig. 4 A) (Huber and Weiss, 1989; Mandeville et al., 1997; Wolf et al., 2003b; Lammermann et al., 2008). Should cancer cell–myeloid 
cell hybrids acquire a similar ability to traffic through collagen networks without mobilizing proteolytic machinery—an as yet unconfirmed poten-
tial—neoplastic cells may prove able to access MT1-MMP–independent programs to negotiate matrix barriers.
In the in vivo setting, caution must be exercised in assuming that ECM pores of sufficient size or structural malleability do not 
exist at select sites in vivo that accommodate protease-independent trafficking (Even-Ram and Yamada, 2005). For example, 
cancer cell trafficking within lymph nodes likely occurs through stromal cell–lined conduits that support rapid movement 
through matrix-free zones (Bajenoff et al., 2006). Further, tissues devoid of interstitial collagen networks, e.g., the brain 
(Pluen et al., 2001), may well be traversed by tumor cells without necessitating proteolytic remodeling while still requiring 
ROCK-regulated molecular motors to squeeze a migrating cell through matrix openings smaller than the short axis of its nu-
cleus (Beadle et al., 2008). Nevertheless, our findings with the normal adult mammary gland, as well as those we described 
previously using human dermal explants (Rosenthal et al., 1998; Sabeh et al., 2004; Hotary et al., 2006), support a model 
wherein the type I collagen architecture of the normal interstitium presents itself as a structural barrier to cancer cell traffic.
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microscopic techniques with conditional 
knockout models and/or the selective si-
lencing of MT-MMP family members in 
primary  populations  of  human  cancer 
cells  embedded  within  the  humanized 
mouse  mammary  gland  (Proia  and   
Kuperwasser, 2006). Although such stud-
ies  are  likely  forthcoming  (Alexander   
et al., 2008; Kedrin et al., 2008), a reduc-
tionist’s  approach  to  modeling  cancer 
cell invasion in vitro suggests that the fre-
quently assumed “given” of cancer cell 
mesenchymal-amoeboid  transitions  that 
allow for protease-
independent  inva-
sion must be viewed 
cautiously as inves-
tigators  attempt  to 
extend  current  in-
sights  into  the  in 
vivo  setting.  In-
deed,  when  con-
fronting  rigid  structural  barriers  whose 
pore  size  is  not  permissive  for  passive 
cell movement, cancer cells appear to be 
almost  entirely  reliant  on  MT1-MMP 
activity,  and  perhaps  the  closely  re-
lated membrane-anchored collagenase   
MT2-MMP (Hotary et al., 2000, 2006). 
Certainly, a “one size fits all” model—even 
regarding the dominant role proposed 
for  MT1-MMP  in  tumor  cell  inva-
sion—seldom  stands  the  test  of  time 
when applied to the complex in vivo 
environment.  No  doubt,  conditions 
will exist in vivo where the cancer cell 
will  use  actomyosin-generated  forces 
to either displace impeding barriers or 
alter  its  nuclear  dimensions  to 
“squeeze” through narrow pores. How-
ever, as important roles for MT-MMP 
family  members 
in cancer invasion, 
growth,  and  sys-
temic  spread  con-
tinue to be defined 
(Taniwaki  et  al., 
2007;  Hu  et  al., 
2008;  Husemann 
et  al.,  2008;   
McGowan  and  Duffy,  2008;  Szabova   
et al., 2008; Devy et al., 2009), care-
fully  controlled  in  vitro  and  in  vivo 
models should allow for new insights 
into the mechanisms controlling can-
cer cell migration through the ECM.
This work was supported by the national Institutes 
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